Compound ID | 990
Class: Natural product antibiotic
| Agent Type: | Natural product; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | DNA synthesis inhibitor. DNA alkylating |
| Target Pathogen: | Weak activity against Gram-positive bacteria |
| Description: | Pluramycin-type; Schmitz, H., K. E. Crook Jr, and J. A. Bush. "Hedamycin, a new antitumor antibiotic. I. Production, isolation, and characterization." Antimicrobial agents and chemotherapy 6 (1966): 606. |
| Institute where first reported: | Bristol-Myers Squibb |
| Year first mentioned: | 1966 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/98033 |
| Guide to Pharmacology: | hedamycin |
| Citation: | https://doi.org/10.1016/1074-5521(95)90273-2 |